LIVN
What one share of LivaNova holds
Electromedical and Electrotherapeutic Apparatus
LivaNova PLC is a market-leading global medical technology company. The Company designs, develops, manufactures, markets, and sells products, therapies, and services that are consistent with LivaNova’s mission to “create ingenious medical solutions that ignite patient turnarounds.” LivaNova is a public limited company organized under the laws of England and Wales and is headquartered in London, England.
LivaNova’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $26.59 |
|---|---|
| Profit | $3.41 |
| Capex (buildings and equipment) | $1.82 |
| Free cash flow | $2.68 |
| Cash and investments | $9.38 |
| Debt | $5.27 |
| Book value | $24.07 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $19.69 | −$1.28 | $0.78 | $1.06 | — | $35.50 |
| 2017 | $20.87 | −$0.52 | $0.68 | $1.20 | — | $37.59 |
| 2018 | $22.83 | −$3.91 | $0.77 | $1.72 | — | $31.13 |
| 2019 | $22.42 | −$3.26 | $0.51 | −$2.40 | — | $28.44 |
| 2020 | $19.23 | −$7.18 | $0.72 | −$2.36 | — | $22.80 |
| 2021 | $20.45 | −$2.68 | $0.50 | $1.52 | — | $24.31 |
| 2022 | $19.11 | −$1.61 | $0.50 | $0.81 | — | $22.55 |
| 2023 | $21.28 | $0.32 | $0.65 | $0.74 | — | $23.70 |
| 2024 | $22.97 | $1.16 | $0.86 | $2.49 | — | $24.29 |
| 2025 | $25.45 | −$4.45 | $1.49 | $3.18 | — | $21.96 |